On November 12, the International Association for the Study of Lung Cancer (IASLC) issued a policy statement that strongly discourages the use of electronic cigarettes (e-cigarettes, or e-cigs) by non-smokers. The timing of the release is [more]
My good friend Professor Richard Sullivan wrote an excellent piece for Cancer World on how to reverse the decline in the benefit per cost of cancer interventions. It gave me food for thought. Sullivan gave [more]
‘Value’ is the latest buzzword in cancer: value-based pricing, delivering value for cancer care, enhancing the value offering for cancer technologies… It makes sense, as focusing on the value of interventions we invest in is [more]
Does robotic surgery offer superior outcomes? Yes and no – or better: yes and maybe – answers a study published earlier this month in The Lancet Oncology: their clinical benefit is still uncertain, but robots [more]